Almost 50% of Healthcare Providers in Asia/Pacific* Plan to Invest in Generative AI Applications, Says IDC


SINGAPORE, August 7, 2023 – Generative AI (GenAI) is set to hyper-personalize care services, as 49.6% of the healthcare providers plan to invest in GenAI use cases, according to a recent IDC report, AI in Healthcare: Redefining Explainability in the context of Generative AI.

This IDC report shows the current landscape and investment trend by the Asia/Pacific healthcare organizations on Generative AI. The report highlights the prominent use cases and potential impact of leveraging GenAI tools in the healthcare sector, both to augment clinician efficiency and to redefine patient experiences.

The report also emphasizes the necessity for “explainability” in the context of Generative AI use case adoptions in healthcare, as diagnosis and treatment-plans by the AI-generated tools have significant impacts on patients’ lives.

Highlights of the report include:

  • Half of the healthcare providers in Asia/Pacific plan to invest in Generative AI technologies.
  • Marketing, Knowledge Management and Conversational applications are the top Generative AI use cases for Asia/Pacific healthcare organizations moving forward, according to IDC Future Enterprise Resiliency and Spending (FERS) survey data.
  • Healthcare organizations in the region are cognizant of the need for ethical aspects. According to FERS survey, while 61% of the healthcare organizations in the region are in the process of adopting data ethics requirements, 14% adhere to ethical aspects of data already in their organizations.

“Generative AI use cases are being adopted across industries. In healthcare, Gen AI has immense potential in addressing inherent challenges to increase productivity, attain hyper-personalization and enhance physician/patient experience by leveraging capabilities of large language models (LLMs). It is imperative that the healthcare organizations be compliant and ensure explainability while adopting such new wave AI-tools”, says Manoj Vallikkat, senior research manager, IDC Asia/Pacific Healthcare Insights.

For more information on this IDC document, please contact Manoj Vallikkat at [email protected]. For media inquiries, please contact Miguel Carreon at [email protected] or Michael de la Cruz at [email protected].

*Asia/Pacific including Japan


IDC Health Insights

IDC Health Insights assists health businesses and IT leaders, in making more effective technology decision by providing insightful fact-based research and consulting services. Our global research analyzes and advises on business and technology issues facing the payer, provider and life sciences industries. For more information, please visit or email [email protected] .

About IDC

International Data Corporation (IDC) is the premier global provider of market intelligence, advisory services, and events for the information technology, telecommunications, and consumer technology markets. With more than 1,300 analysts worldwide, IDC offers global, regional, and local expertise on technology and industry opportunities and trends in over 110 countries. IDC’s analysis and insight helps IT professionals, business executives, and the investment community to make fact-based technology decisions and to achieve their key business objectives. Founded in 1964, IDC is a wholly-owned subsidiary of International Data Group (IDG), the world’s leading tech media, data and marketing services company. To learn more about IDC, please visit Follow IDC on Twitter at @IDCAP and LinkedIn. Subscribe to the IDC Blog for industry news and insights.



Leave a Reply

Your email address will not be published. Required fields are marked *